Vegf expression, cellular infiltration, and intratumoral collagen levels after electroporation-based treatment of dogs with cutaneous squamous cell carcinoma

• Autor(a) principal: Dos Anjos, Denner [UNESP]
• Data de Publicação: 2021
• Outros Autores: Bueno, Cynthia [UNESP], Mattos-Junior, Ewaldo, De Nardi, Andrigo Barboza [UNESP], Fonseca-Alves, Carlos Eduardo [UNESP]
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UNESP
• Texto Completo: http://dx.doi.org/10.3390/life11121321; http://hdl.handle.net/11449/223096
• topic: Bleomycin; Cutaneous carcinoma; Doxorubicin; Electrochemotherapy; Electroporation-based treatment; Masson’s trichrome

Canine cutaneous squamous cell carcinoma (SCC) is the most common type of skin cancer in tropical countries and is generally associated with exposure to solar ultraviolet light. It has a low metastatic rate, and local treatments, such as electrochemotherapy (ECT), promote long-term control or even complete remission. This study aimed to evaluate pre-and post-ECT treatment expression levels of vascular endothelial growth factor (VEGF) and CD31, cellular infiltration, and intratumoral collagen levels in dogs with cutaneous SCC. A prospective nonrandomized clinical study was performed using dogs with spontaneous SCC treated with ECT. Eighteen lesions from 11 dogs were included in the study. The expression levels of VEGF and CD31; cellular infiltration; and intratumoral collagen levels, as determined by Masson’s trichrome staining, were not significantly different from pre-treatment measurements on day 21 (p > 0.05). However, among cellular infiltration, the mixed subtype was correlated with better overall survival time when compared to lymphoplasmacytic and neutrophilic infiltration (p < 0.05). In conclusion, ECT had no effect on VEGF expression, cellular infiltration, or intratumoral collagen levels in dogs with cutaneous SCC at the time of evaluation, suggesting that early and late post-ECT-treatment phases should be considered.